These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28653984)

  • 41. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
    Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
    Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma.
    Chen D; Zhang Z; Mao C; Zhou Y; Yu L; Yin Y; Wu S; Mou X; Zhu Y
    Cell Immunol; 2014; 289(1-2):91-6. PubMed ID: 24747824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ANRIL overexpression globally induces expression and alternative splicing of genes involved in inflammation in HUVECs.
    Wufuer A; Luohemanjiang X; Du L; Lei J; Shabier M; Han DF; Ma J
    Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36524379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144.
    Ma Y; Zhang H; Li G; Hu J; Liu X; Lin L
    Anticancer Drugs; 2019 Nov; 30(10):1013-1021. PubMed ID: 31609763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
    J Hematol Oncol; 2015 May; 8(1):57. PubMed ID: 27391317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.
    Xu S; Wang H; Pan H; Shi Y; Li T; Ge S; Jia R; Zhang H; Fan X
    Cancer Lett; 2016 Oct; 381(1):41-8. PubMed ID: 27461581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
    Nie FQ; Sun M; Yang JS; Xie M; Xu TP; Xia R; Liu YW; Liu XH; Zhang EB; Lu KH; Shu YQ
    Mol Cancer Ther; 2015 Jan; 14(1):268-77. PubMed ID: 25504755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Research advance of ANRIL on atherosclerosis by regulating cell proliferation and apoptosis].
    Fang J; Pan Z; Guo X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):113-117. PubMed ID: 32621415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
    Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.
    Parker CJ; Shawcross SG; Li H; Wang QY; Herrington CS; Kumar S; MacKie RM; Prime W; Rennie IG; Sisley K; Kumar P
    Int J Cancer; 2004 Jan; 108(2):314-20. PubMed ID: 14639621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 May; 37(5):5657-61. PubMed ID: 26753962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome.
    Vanneste R; Smith E; Graham G
    Am J Med Genet A; 2013 Jun; 161A(6):1425-31. PubMed ID: 23613284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro.
    Sun Y; Zheng ZP; Li H; Zhang HQ; Ma FQ
    Mol Med Rep; 2016 Aug; 14(2):1714-20. PubMed ID: 27314206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
    Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
    J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression ratio of circular to linear ANRIL in hypertensive patients with coronary artery disease.
    Razeghian-Jahromi I; Zibaeenezhad MJ; Karimi Akhormeh A; Dara M
    Sci Rep; 2022 Feb; 12(1):1802. PubMed ID: 35110626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.
    Sun C; Shen C; Zhang Y; Hu C
    Adv Clin Exp Med; 2021 Jan; 30(1):55-65. PubMed ID: 33529508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PacBio full-length cDNA sequencing integrated with RNA-seq reads drastically improves the discovery of splicing transcripts in rice.
    Zhang G; Sun M; Wang J; Lei M; Li C; Zhao D; Huang J; Li W; Li S; Li J; Yang J; Luo Y; Hu S; Zhang B
    Plant J; 2019 Jan; 97(2):296-305. PubMed ID: 30288819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1.
    Sato K; Nakagawa H; Tajima A; Yoshida K; Inoue I
    Oncol Rep; 2010 Sep; 24(3):701-7. PubMed ID: 20664976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
    Poi MJ; Li J; Sborov DW; VanGundy Z; Cho YK; Lamprecht M; Pichiorri F; Phelps MA; Hofmeister CC
    Mol Carcinog; 2017 Jul; 56(7):1722-1732. PubMed ID: 28150872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.